Pages that link to "Q40093200"
Jump to navigation
Jump to search
The following pages link to β-Adrenergic Blockade for Survivors of Acute Myocardial Infarction (Q40093200):
Displaying 50 items.
- Cardioselective beta-blockers for chronic obstructive pulmonary disease (Q24245649) (← links)
- Secondary prevention of myocardial infarction: role of beta-adrenergic blockers and angiotensin-converting enzyme inhibitors (Q33546230) (← links)
- Antihypertensive therapy in the prevention of stroke: what, when and for whom? (Q33768748) (← links)
- Secondary prevention in acute myocardial infarction (Q33789369) (← links)
- Current concepts in secondary prevention after acute myocardial infarction (Q33860933) (← links)
- Therapeutic developments in sudden cardiac death (Q34075156) (← links)
- Recommendations from the Canadian Hypertension Society Consensus Conference on the Pharmacologic Treatment of Hypertension. (Q34103560) (← links)
- Cardioselective beta-blockers for reversible airway disease (Q34116299) (← links)
- The silent coronary (Q34491963) (← links)
- Cardioselective beta-blockers for chronic obstructive pulmonary disease. (Q34699281) (← links)
- Use of beta-blockers in patients with COPD. (Q35638083) (← links)
- Under-use of beta-blockers in patients with ischaemic heart disease and concomitant chronic obstructive pulmonary disease (Q36162987) (← links)
- Drug Treatment of Hypertension: Controlling elevated blood pressure (Q36283142) (← links)
- Clinical perspective on celiprolol: Cardioprotective potential (Q36482914) (← links)
- Medical Therapy of the Hypertensive Patient with Concomitant Angina Pectoris (Q36495359) (← links)
- Evidence for or against efficacy of beta-blockers and aspirin for management of feline cardiomyopathies (Q36531820) (← links)
- Cardiovascular therapies in the 1990s. An overview (Q36657476) (← links)
- Effect of β-adrenergic blocking agents on mortality rate in patients not revascularized after myocardial infarction: Data from a large HMO (Q36888654) (← links)
- Sudden Death: Evaluation and Prevention (Q37041256) (← links)
- Beta-blockers use in patients with chronic obstructive pulmonary disease and concomitant cardiovascular conditions (Q37082599) (← links)
- Parasympathetic effects on cardiac electrophysiology during exercise and recovery in patients with left ventricular dysfunction (Q37298282) (← links)
- Change in mRNA Expression after Atenolol, a Beta-adrenergic Receptor Antagonist and Association with Pharmacological Response (Q37412451) (← links)
- New drugs for the treatment of hypertension: where do they fit? (Q37832147) (← links)
- β-Adrenergic Blockers (Q37928128) (← links)
- β-Adrenergic blockade in cardiovascular disease (Q38103516) (← links)
- Current management of acute myocardial infarction (Q38365112) (← links)
- Use of beta-adrenergic blocking agents after myocardial infarction (Q39406756) (← links)
- Recent advances in beta-adrenergic blocking agents (Q39453178) (← links)
- The effects of antihypertensive drugs on serum lipids and lipoproteins. II. Non-diuretic drugs (Q39460803) (← links)
- Beta-adrenergic blockers. (Q39466013) (← links)
- After the infarct. (Q39599105) (← links)
- Chronic β1-adrenoceptor blockade impairs ischaemic tolerance and preconditioning in murine myocardium (Q39635677) (← links)
- Are calcium antagonists cardioprotective? (Q39820751) (← links)
- The use of β-adrenergic blocking drugs in patients with myocardial infarction (Q40094755) (← links)
- Mechanisms contributing to precipitation of unstable angina and acute myocardial infarction: Implications regarding therapy (Q40095953) (← links)
- Effect of propranolol in patients with myocardial infarction and ventricular arrhythmia (Q41449238) (← links)
- Beta-adrenergic receptor properties of canine myocardium: effects of chronic myocardial infarction (Q41841985) (← links)
- Interpretation of the emergency electrocardiogram by junior hospital doctors (Q42101913) (← links)
- Impact of Acute Propranolol Administration on Dobutamine-Induced Myocardial Ischemia as Evaluated by Myocardial Perfusion Imaging and Echocardiography (Q42548118) (← links)
- Two cheers for meta-analysis: problems and opportunities in aggregating results of clinical trials (Q42593071) (← links)
- Cardioprotective and antiarrhythmic effects of beta-blockers, propranolol, bisoprolol, and nipradilol in a canine model of regional ischemia (Q43652808) (← links)
- Prevention of sudden death in survivors of myocardial infarction: A decision analysis approach (Q44354297) (← links)
- Anti-Ischemic Effects of Ivabradine, a Selective Heart Rate-Reducing Agent, in Exercise-Induced Myocardial Ischemia in Pigs (Q44630602) (← links)
- William Howard Frishman, MD: a conversation with the editor. Interview by William Clifford Roberts (Q50272338) (← links)
- Experimental studies of electroacupuncture on ventricular fibrillation threshold in rats with acute ischemic myocardium (Q51402200) (← links)
- Characterization of the Factors that Determine the Effect of Sympathetic Stimulation on Heart Rate Variability (Q51538096) (← links)
- Cardioselective beta-blockers for chronic obstructive pulmonary disease: a meta-analysis. (Q51648717) (← links)
- The effects of orally administered atenolol on the coronary hemodynamics and prostaglandin metabolism in angina pectoris patients. (Q54212560) (← links)
- Morphine, Oxygen, Nitrates, and Mortality Reducing Pharmacological Treatment for Acute Coronary Syndrome: An Evidence-based Review. (Q54957485) (← links)
- Left ventricular function and prognosis after myocardial infarction: Rationale for therapeutic strategies (Q57842107) (← links)